Director · UNITED THERAPEUTICS Corp · Common Stock
Side
SELL
Value
$23K
Shares
50
Price
$460.98
Executed
Jan 16, 2026
Disclosed
Jan 20, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Jan 16 executedJan 20, 2026 disclosed
UTHR · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+4 / 15
3 prior trades recorded in this security
Frequency & clustering+5 / 15
1 other actor traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Malcolm Jan filed this Form 4 reporting a open-market sale of UTHR on Jan 16, 2026. It became public on Jan 20, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Malcolm Jancik:0002028640
Issuer
UNITED THERAPEUTICS Corpcik:0001082554
Revision history · 0
No field has changed since this record was first ingested.
